THE IMPACT OF ACHIEVING “PERFECT CARE” ON CARDIOVASCULAR OUTCOMES IN ACUTE CORONARY SYNDROME  by Milani, Richard V. et al.
E1223
JACC April 5, 2011
Volume 57, Issue 14
  QUALITY OF CARE AND OUTCOMES ASSESSMENT 
THE IMPACT OF ACHIEVING “PERFECT CARE” ON CARDIOVASCULAR OUTCOMES IN ACUTE CORONARY 
SYNDROME
ACC Poster Contributions
Ernest N. Morial Convention Center, Hall F
Monday, April 04, 2011, 9:30 a.m.-10:45 a.m.
Session Title: Quality of Care: Guidelines and pathways 1
Abstract Category: 44. Quality of Care
Session-Poster Board Number: 1099-153
Authors: Richard V. Milani, Carl J. Lavie, Elise L. Milani, John Ochsner Heart and Vascular Institute, New Orleans, LA, Ochsner Clinical School -- The 
University of Queensland School of Medicine, New Orleans, LA
Background:  Evidence from randomized clinical trials and consensus guidelines suggest that in-hospital initiation of key pharmacotherapeutics 
can substantially reduce short and long-term mortality and morbidity in patients admitted with an acute coronary syndrome (ACS). Despite this, 
several studies have documented underprescription of these agents. As a result, the AHA and ACC have co-developed guideline-based “performance 
measures” such that when every measure has been completed, the patient is considered to have achieved optimal or “perfect care” (PC). We sought 
to describe the frequency of PC in contemporary ACS patients and to evaluate its attainment on clinical outcomes.
Methods:  We recorded clinical characteristics, hospital length of stay (LOS), 30 and 90-day mortality in 843 consecutive ACS patients and 
compared clinical characteristics and outcomes in patients who achieved PC (PC+) to those who did not (PC-).
Results:  PC was achieved in 75% of all patients, and was associated with a higher TIMI risk score and a borderline lower peak troponin as well as 
a 20% reduction in LOS (p=0.08) (Table). Attainment of PC was associated with a 65-70% reduction in 30 and 90-day mortality (both p≤ 0.01).
Conclusions:  Achievement of PC in ACS patients is attainable via improved processes of care, and is associated with a reduced hospital length of 
stay and a marked reduction in mortality. Clinicians and hospitals should strengthen efforts towards processes of care that lead to PC in all eligible 
ACS patients.






Age 67 ± 13 68 ± 14 NS
Male (%) 65% 62% NS
STEMI (%) 9% 12% NS
Peak troponin (mg/dl) 4.9 ± 11.9 7.3 ± 13.8 0.06
Ejection fraction (%) 50 ± 14 48 ± 16 NS
TIMI Risk (units) 3.2 ± 1.6 2.9 ± 1.7 0.02
Length of stay (days) 3.6 ± 5.9 4.5 ± 6.4 0.08
30-day mortality (%) 1.4% 4.8% 0.01
90-day mortality (%) 2.1% 6.2% 0.005
